Lassa Virus Reverse Genetics.

Area of Science:

• Virology
• Molecular Biology
• Pathogenesis

Background:

• Lassa virus (LASV) causes Lassa fever (LF), a severe hemorrhagic fever (HF) in West Africa with high morbidity and mortality.
• Current treatments are limited, with no licensed vaccines available for LASV infections.
• Ribavirin (Rib) is used off-label but shows only partial effectiveness against LASV.

Purpose of the Study:

• To summarize state-of-the-art experimental procedures for implementing LASV reverse genetics.
• To discuss translational research advancements enabled by LASV reverse genetics.
• To highlight the utility of reverse genetics in studying LASV molecular biology and pathogenesis.

Main Methods:

• Utilizing cell-based LASV minigenome (MG) systems to study genome replication and transcription.
• Employing reverse genetics to rescue infectious recombinant (r)LASV from cDNA.
• Investigating virus-host interactions and pathogenesis using engineered LASV.

Main Results:

• LASV reverse genetics facilitates examination of cis- and trans-acting factors.
• Identification of novel drug targets for LASV is achievable through MG systems.
• rLASV rescue enables detailed studies of virus-host interactions and pathogenesis.

Conclusions:

• Reverse genetics is a powerful tool for LASV research, advancing understanding of its molecular biology and pathogenesis.
• This approach facilitates the discovery of new antiviral drugs and the development of live-attenuated vaccines (LAV).
• LASV reverse genetics is crucial for developing effective countermeasures against Lassa fever.